BACKGROUND: Cigarette smoking is a major risk factor for several chronic diseases. Epidemiological data indicate the use of smokeless tobacco (ST) is associated with significantly lower risk for smoking-related diseases compared to cigarettes. Several biomarkers of exposure (BioExp) and effect (BioEff) associated with smoking and use of moist snuff (ST) were evaluated. METHODS: A single site, cross-sectional clinical study enrolled three groups of generally healthy male smokers (SMK), moist snuff consumers (MSC), and non-tobacco consumers (NTC), and several BioExp and BioEff were evaluated. RESULTS: Blood and urinary BioExp, including total nicotine equivalents and tobacco-specific nitrosamines, were higher in MSC compared to SMK. Biomarkers of combustion-related toxicants and cadmium were elevated in SMK. Elevated levels of some BioEff associated with oxidative stress (urinary isoprostanes and leukotriene E4), inflammation (white blood cell count), platelet activation (thromboxane metabolites), and lipid metabolism (apolipoprotein B100 and oxidized low-density lipoprotein) were observed in SMK relative to NTC and MSC (all p<0.05). The non-smoking groups (MSC and NTC) showed similar levels of combustion-related BioExp and BioEff. CONCLUSIONS: Higher levels of exposure to nicotine and some N'-nitrosamines may be observed in MSC, and SMK are exposed to higher levels of combustion-related toxicants. Changes in BioEff consistent with some aspects of inflammation, oxidative stress, and altered lipid metabolism were detected in SMK compared to the non-smoking groups. The biomarker data further improve our understanding of pathophysiological changes and the risk continuum associated with various tobacco products, and could be useful components of future assessments of tobacco products.
BACKGROUND: Cigarette smoking is a major risk factor for several chronic diseases. Epidemiological data indicate the use of smokeless tobacco (ST) is associated with significantly lower risk for smoking-related diseases compared to cigarettes. Several biomarkers of exposure (BioExp) and effect (BioEff) associated with smoking and use of moist snuff (ST) were evaluated. METHODS: A single site, cross-sectional clinical study enrolled three groups of generally healthy male smokers (SMK), moist snuff consumers (MSC), and non-tobacco consumers (NTC), and several BioExp and BioEff were evaluated. RESULTS: Blood and urinary BioExp, including total nicotine equivalents and tobacco-specific nitrosamines, were higher in MSC compared to SMK. Biomarkers of combustion-related toxicants and cadmium were elevated in SMK. Elevated levels of some BioEff associated with oxidative stress (urinary isoprostanes and leukotriene E4), inflammation (white blood cell count), platelet activation (thromboxane metabolites), and lipid metabolism (apolipoprotein B100 and oxidized low-density lipoprotein) were observed in SMK relative to NTC and MSC (all p<0.05). The non-smoking groups (MSC and NTC) showed similar levels of combustion-related BioExp and BioEff. CONCLUSIONS: Higher levels of exposure to nicotine and some N'-nitrosamines may be observed in MSC, and SMK are exposed to higher levels of combustion-related toxicants. Changes in BioEff consistent with some aspects of inflammation, oxidative stress, and altered lipid metabolism were detected in SMK compared to the non-smoking groups. The biomarker data further improve our understanding of pathophysiological changes and the risk continuum associated with various tobacco products, and could be useful components of future assessments of tobacco products.
Authors: Jamaji C Nwanaji-Enwerem; Andres Cardenas; Peter R Chai; Marc G Weisskopf; Andrea A Baccarelli; Edward W Boyer Journal: Nicotine Tob Res Date: 2019-08-19 Impact factor: 4.244
Authors: June Feng; Connie S Sosnoff; John T Bernert; Benjamin C Blount; Yao Li; Arseima Y Del Valle-Pinero; Heather L Kimmel; Dana M van Bemmel; Sharyn M Rutt; Juan Crespo-Barreto; Nicolette Borek; Kathryn C Edwards; Ricky Alexander; Stephen Arnstein; Charles Lawrence; Andrew Hyland; Maciej L Goniewicz; Imran Rehmani; Brittany Pine; Vincent Pagnotti; Erin Wade; James Sandlin; Zuzheng Luo; Sujeewa Piyankarage; Dorothy K Hatsukami; Stephen S Hecht; Kevin P Conway; Lanqing Wang Journal: Nicotine Tob Res Date: 2022-03-26 Impact factor: 5.825
Authors: Georges J Nahhas; K Michael Cummings; Michael J Halenar; Eva Sharma; Anthony J Alberg; Dorothy Hatuskami; Maansi Bansal-Travers; Andrew Hyland; Diann E Gaalema; Pamela B Morris; Kara Duffy; Joanne T Chang; Guy Lagaud; Juan C Vivar; Daniela Marshall; Carlos Blanco; Kristie A Taylor Journal: Prev Med Rep Date: 2021-11-30